Skip to content

Drug-induced Kidney Injury Model

Establishment, Evaluation and Treatment Strategy of Drug-induced Kidney Injury Model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06939387
Enrollment
1500
Registered
2025-04-22
Start date
2025-03-10
Completion date
2026-12-30
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

acute kidney injury, drug

Brief summary

To establish the prediction model of renal dysfunction in patients with drug-induced renal injury and study the prognosis of different drug treatments

Interventions

Observational study, no intervention

Sponsors

Taizhou Enze Medical Center Group
CollaboratorOTHER
Hangzhou Linping District first People's Hospital
CollaboratorUNKNOWN
Aksu district first People's Hospital
CollaboratorUNKNOWN
Ningbo Yinzhou District Second Hospital
CollaboratorUNKNOWN
Wucheng District First People's Hospital
CollaboratorUNKNOWN
Zhejiang Provincial People's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Drug-induce acute kidney injury

Exclusion criteria

* 1.Dialysis patients; 2.No baseline creatinine; 3.Obstructive AKI; 4.Clinical data were incomplete.

Design outcomes

Primary

MeasureTime frameDescription
Model performance metrics assessed by AUC-ROC, accuracy and F1-score using 10-fold cross-validationthrough study completion, an average of 6 monthsThe prognosis of renal function was evaluated by measuring creatinine and proteinuria by laboratory tests. Predict outcomes using machine learning methods. And the prediction effect of the prediction model was evaluated by AUC-ROC, F1, accuracy and other indicators.

Secondary

MeasureTime frame
The rate at which creatinine falls7 days, 1 month, 3 months after treatment

Countries

China

Contacts

Primary Contactxiaolan Ye, master
yexl1120@126.com+86-0571-85893117
Backup ContactPing Huang, doctor
huangping1841@zjcc.org.cn+86-0571-85893117

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026